As of the latest Form 4 filed Jun 4, 2026.
What Nutex Health Inc insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 20 most recent filings for NUTX.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-04 | 2026-06-04 | Spears Kelvin Director | JOther | +2.52K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-29 | 2026-05-28 | Vo Thomas T. Chief Executive Officer | JOther | +75.7K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-10 | 2026-04-09 | Vo Thomas T. Chief Executive Officer | JOther | +184K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-23 | 2026-03-20 | Jaumot Frank E Director | PPurchase | +150.00 | $93.56 | $14.0K | No | Form 4 ↗ |
| 2026-03-23 | 2026-03-19 | Hosseinion Warren President | PPurchase | +252.00 | $94.07 | $23.7K | No | Form 4 ↗ |
| 2026-03-18 | 2026-03-17 | Spears Kelvin Director | PPurchase | +10.00 | $94.46 | $944.60 | No | Form 4 ↗ |
| 2026-03-16 | 2026-03-13 | Montgomery Pamela W. Chief Legal Officer-Healthcare | PPurchase | +79.00 | $88.87 | $7.02K | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-10 | Spears Kelvin Director | FTax | −82.00 | $86.22 | $7.07K | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-10 | Spears Kelvin, Director | MExercise | +183.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-10 | Bates Jon Christian Chief Financial Officer | MExercise | +2.67K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-10 | Vo Thomas T. Chief Executive Officer | FTax | −3.02K | $86.22 | $260K | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-10 | Vo Thomas T., Chief Executive Officer | MExercise | +8.33K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-10 | Chang Michael L. Chief Medical Officer | FTax | −769.00 | $86.22 | $66.3K | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-10 | Chang Michael L., Chief Medical Officer | MExercise | +2.08K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-10 | Montgomery Pamela W. Chief Legal Officer-Healthcare | FTax | −776.00 | $86.22 | $66.9K | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-10 | Montgomery Pamela W., Chief Legal Officer-Healthcare | MExercise | +2.08K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-10 | Luqman Elisa V Chief Legal Officer - SEC | FTax | −784.00 | $86.22 | $67.6K | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-10 | Luqman Elisa V, Chief Legal Officer - SEC | MExercise | +2.08K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-10 | Hosseinion Warren President | FTax | −3.27K | $86.22 | $282K | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-10 | Hosseinion Warren, President | MExercise | +6.29K | $0.00 | $0.00 | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also NUTX’s full analysis or the market-wide insider trading feed. The tabs above jump to NUTX’s other SEC data.
Source: SEC Form 4 filings for NUTX, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.